7-Bromo-2,4-dichlorothieno[3,2-d]pyrimidine

Catalog No.: 
ACZHXV064
CAS No.: 
41102-25-4
Molecular Formula: 
C6HBrCl2N2S
Molecular Weight: 
283.96
7-Bromo-2,4-dichlorothieno[3,2-d]pyrimidine structure diagram
Pack SizePurityList PriceYour PriceGlobal StockUS StockQuantity
1g95%$92.00In stockInquiry
5g95%$319.00In stockInquiry
25g95%$1590.00InquiryInquiry

Products of AiFChem are all designed for scientific research only. Under no circumstances do we provide products or services for animal or personal utilization.

Product Information

Product Name7-Bromo-2,4-dichlorothieno[3,2-d]pyrimidine
IUPAC Name7-bromo-2,4-dichlorothieno[3,2-d]pyrimidine
MDL No.MFCD11869289
Molecular FormulaC6HBrCl2N2S
Molecular Weight283.96
SMILESClC1=C2C(C(Br)=CS2)=NC(Cl)=N1
InChI KeySELNIRJYLYMJKG-UHFFFAOYSA-N
Synonym7-Bromo-2,4-dichlorothieno[3,2-d]pyrimidine | 41102-25-4 | 7-Bromo-2,4-dichloro-thieno[3,2-d]pyrimidine | MFCD11869289 | SCHEMBL1284962 | CHEMBL3236404 | DTXSID60592815 | SELNIRJYLYMJKG-UHFFFAOYSA-N | AKOS015835733 | PB31616 | AS-42536 | SY098467 | CS-0050093 | FT-0683038 | EN300-32
CAS No.41102-25-4
PubChem CID18326422

Safety Data

Pictogram
Harmful or irritant
Signal Word
Warning
Hazard Statement(s)
H302-H315-H319-H335
Precautionary Statement(s)
P261-P305+P351+P338

Synthetic Route by SureRoute

1. ACZHXV064 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. ACFSXQ831 route compound structure diagram
    ACFSXQ83141102-02-7In Stock
  2. Then
  3. ACZHXV064 route product structure diagram
    ACZHXV06441102-25-4In Stock
Inquiry

2. ACZHXV064 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Then
  3. ACZHXV064 route product structure diagram
    ACZHXV06441102-25-4In Stock
Inquiry

3. ACZHXV064 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Then
  3. ACZHXV064 route product structure diagram
    ACZHXV06441102-25-4In Stock
Inquiry

Comments (0)